-
Diffusion Pharmaceuticals (NASDAQ:DFFN) In Advanced Trial Stages For TSC While The Stock Continues To Hold ...
Diffusion Pharmaceuticals (NASDAQ:DFFN) is in the advanced stages of Phase 3 trials for trans sodium crocetinate (TSC). The product is ...